全球生物淨化市場規模（按產品類型、代理、最終用戶、區域範圍和預測）

生物淨化市場規模與預測

2024 年生物淨化市場規模為 1.4983 億美元，預計到 2032 年將達到 2.0854 億美元，2026 年至 2032 年的複合年成長率為 4.22%。

生物去污是消除微生物污染或將微生物污染降低到可接受水平的過程。在各種環境中，生物去污都至關重要，因為細菌的存在會對健康造成嚴重危害。

生物去污是在隔離室、重症監護室和手術室等醫院環境中進行的，以防止病原體的傳播。

此外，製藥和生物技術公司也使用它來確保產品純度和員工安全。

全球生物淨化市場動態

影響生物淨化市場的關鍵市場動態是：

關鍵市場促進因素

醫療相關感染 (HAI) 的增加：HAI 的增加是生物淨化市場的主要驅動力。根據美國疾病管制與預防中心 (CDC) 的數據，每 31 名住院患者中就有 1 名每天至少患有一次醫療相關感染。這些高發病率凸顯了醫療保健環境中強大的生物淨化解決方案對於限制疾病傳播和確保患者安全的關鍵性。

製藥和生物技術產業的成長：製藥和生物技術產業的成長增加了對生物淨化服務和產品的需求。 FDA 報告稱，2022 年核准了37 種創新藥物，顯示該產業正在持續擴張和創新。這種成長與對無菌工業環境和污染控制方法的需求不斷增加直接相關，從而推動了生物淨化市場的發展。

嚴格的監管標準：許多行業對清潔度和無菌度的嚴格規定正在推動生物淨化市場的發展。例如，歐洲藥品管理局（EMA）將於2024年8月實施歐盟GMP附件1，為無菌醫療產品的生產制定詳細規則。該規則強調了採取污染預防措施的必要性，並鼓勵使用先進的生物去污技術和服務。

主要問題

高成本：生物淨化技術和服務的成本高，包括設備和基礎設施的初始投資，限制了其採用，特別是在資源貧乏的環境和開發中國家。這種成本障礙阻礙了這些重要淨化方法的廣泛使用。

缺乏認知：在某些地方，人們缺乏對生物去污的重要性和好處的認知，導致採用率低。教育最終用戶並強調保持清潔衛生環境的重要性對於克服這一限制至關重要。

病原體抗藥性的多變性：不同感染疾病的抗藥性水平會影響生物淨化程序的有效性，從而難以確保一致、準確的淨化結果。解決這種變化對於持續的市場發展至關重要。

主要趨勢

過氧化氫蒸氣(HPV) 技術的應用日益廣泛：HPV 因其對多種細菌的有效性、材料相容性以及能夠到達難以觸及的地方而越來越受歡迎。製造商正致力於開發攜帶式、易於使用的 HPV 消毒設備。

製藥業對生物淨化的需求不斷成長：製藥業是生物淨化技術的主要用戶，以確保製造設施、設備和成品的無菌性。生技藥品和先進藥物的興起正在推動對有效清洗技術的需求。

更重視醫療保健中的預防措施和感染控制：醫療保健產業正在專注於預防措施和感染控制，以減少醫療保健相關感染 (HAI) 的數量。生物去污對於維持醫院的無菌環境至關重要，尤其是重症監護室和手術室。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 生物淨化市場（依產品）

• 裝置
• 耗材

第5章 生物去污市場（按藥劑）

• 過氧化氫
• 二氧化氯
• 過氧乙酸
• 二氧化氮

第6章。按類型分類的生物淨化市場

• 腔室淨化
• 房間淨化

第7章 生物淨化市場（依最終用戶）

• 製藥和醫療設備製造商
• 契約製造和研究機構
• 醫院醫療保健設施
• 其他

第8章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第9章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第10章 競爭格局

• 主要企業
• 市場佔有率分析

第11章 公司簡介

• STERIS（美國）
• Bioquell (Ecolab) (英國)
• JCE BIoTechnology（法國）
• Fedegari Autoclavi SpA（義大利）
• TOMI環境解決方案公司（美國）

第12章 市場展望市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第13章 附錄

• 簡稱列表
• 來源和參考文獻

Bio Decontamination Market Size and Forecast

Bio Decontamination Market size was valued at USD 149.83 Million in 2024 and is projected to reach USD 208.54 Million by 2032, growing at a CAGR of 4.22% from 2026 to 2032.

Bio decontamination is the process of eliminating or lowering microbial contamination to a tolerable level. It is critical in a variety of settings where the presence of germs might offer serious health hazards.

Bio decontamination is used in hospital environments such as isolation rooms, critical care units, and operating theaters to avoid the transmission of pathogens.

Furthermore, it is also utilized in pharmaceutical and biotechnology companies to ensure product purity and employee safety.

Global Bio Decontamination Market Dynamics

The key market dynamics that are shaping the bio decontamination market include:

Key Market Drivers

Increasing Healthcare-Associated Infections (HAIs): The increased number of HAIs is a primary driver of the bio decontamination market. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one healthcare-associated infection on any given day. This high incidence highlights the crucial need for robust bio decontamination solutions in healthcare settings to limit the spread of illnesses and ensure patient safety.

Growing Pharmaceutical and Biotechnology Industries: The growth of the pharmaceutical and biotechnology industries is increasing the demand for bio decontamination services and products. The FDA reported that 37 innovative medications were approved in 2022, demonstrating the industry's ongoing expansion and innovation. This rise is directly related to an increased demand for sterile industrial environments and contamination control methods, which is driving the bio decontamination market.

Stringent Regulatory Standards: Stricter restrictions on cleanliness and sterility in many industries are driving the bio decontamination market ahead. For instance, the European Medicines Agency (EMA) implemented EU GMP Annex 1 in August 2024, which establishes detailed rules for the production of sterile medical goods. This rule highlights the necessity of contamination control measures, which encourages the use of sophisticated bio decontamination technology and services.

Key Challenges:

High Cost: The high cost of bio decontamination technologies and services, including the initial investment in equipment and infrastructure, restricts uptake, particularly in resource-constrained settings and developing countries. This cost barrier prevents the widespread adoption of these crucial decontamination methods.

Lack of Awareness: In some locations, there is a lack of awareness regarding the importance and benefits of bio decontamination, resulting in lower adoption rates. Educating end users and stressing the importance of keeping clean and sanitary settings is critical for overcoming this constraint.

Variability in Pathogen Resistance: Different infections' resistance levels affect the efficacy of bio decontamination procedures, making it difficult to ensure consistent and accurate decontamination results. Addressing this variability is critical to the market's continued development.

Key Trends:

Increasing Adoption of Hydrogen Peroxide Vapor (HPV) Technology: HPV is gaining popularity due to its efficiency against a wide spectrum of germs, material compatibility, and ability to reach inaccessible locations. Manufacturers are concentrating on creating portable and user-friendly HPV disinfection equipment.

Growing Demand for Bio Decontamination in the Pharmaceutical Industry: The pharmaceutical business is a major user of bio decontamination technology to ensure the sterility of manufacturing facilities, equipment, and finished goods. The growth of biologics and sophisticated medicines is increasing the demand for effective cleaning technologies.

Increasing Focus on Preventive Measures and Infection Control in Healthcare: The healthcare industry is focusing on preventative measures and infection control to lower the number of healthcare-associated infections (HAIs). Bio decontamination is vital for maintaining a sterile environment in hospitals, particularly critical care units and operating rooms.

Global Bio Decontamination Market Regional Analysis

Here is a more detailed regional analysis of the bio decontamination market:

North America:

According to Verified Market Research, North America is estimated to dominate during the forecast period. North America, particularly the United States, leads in healthcare spending, resulting in increased investment in advanced bio decontamination technologies. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending will total $4.3 trillion in 2021, accounting for 18.3% of the country's GDP. This significant investment promotes the use of cutting-edge bio decontamination solutions in healthcare facilities throughout the region.

North America has some of the strictest rules for cleanliness and sterility in healthcare and pharmaceutical facilities. The United States Food and Medication Administration (FDA) said that in fiscal year 2022, it conducted over 3,000 inspections of human medication manufacturing plants to ensure compliance with good manufacturing standards. This regulatory pressure promotes the market for effective bio-decontamination goods and services to meet these high standards.

Furthermore, North America has a large biotechnology and pharmaceutical industry, which necessitates severe bio decontamination protocols. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry invested an estimated $102.3 billion in research and development in 2021. This significant investment and expansion in the sector is directly related to an increased demand for bio decontamination solutions to maintain sterile research and manufacturing environments.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. The Asia Pacific region is rapidly expanding its healthcare facilities, resulting in increased demand for bio decontamination services and goods. According to the Asian Development Bank, healthcare spending in the Asia-Pacific region is expected to reach USD 2.4 Trillion by 2032, expanding at a CAGR of 6.3% between 2014 and 2032. This significant investment in healthcare infrastructure demands cutting-edge bio decontamination solutions to maintain sterile surroundings and avoid illness.

The increased incidence of HAIs in the region is a significant driver of the bio decontamination market. According to a study published in the Lancet Global Health, the prevalence of HAIs in Southeast Asia is over 9.0%, much higher than the global average of 7.6%. The high incidence emphasizes the urgent need for effective bio decontamination measures in healthcare settings across the Asia Pacific region.

Furthermore, the fast growth of the pharmaceutical and biotechnology sectors in the Asia Pacific is driving up demand for bio decontamination products and services. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical sector alone is anticipated to be worth USD 130 Billion by 2032, increasing at a 12.3% CAGR. Similarly, McKinsey & Company estimates that China's pharmaceutical market would approach USD $300 Billion by 2025. This exponential rise in these industries needs strict contamination control methods, which is driving the regional bio decontamination market.

Europe:

Europe region is estimated to exhibit substantial growth during the forecast period. Europe's aging population is increasing the demand for healthcare services, which in turn raises the demand for bio decontamination in medical institutions. According to Eurostat, the proportion of adults 65 and older in the EU is expected to rise from 20.8% in 2021 to 31.3% by 2100. This demographic transition is projected to increase hospital admissions and medical treatments, needing strict bio decontamination measures to prevent healthcare-associated infections.

Europe has enacted stringent cleanliness and sterility rules in a variety of industries, most notably healthcare and pharmaceuticals. For example, the European Union's Good Manufacturing Practice (GMP) guidelines, which include the recently amended Annex 1 for sterile pharmaceutical products, establish stringent contamination control requirements. The European Medicines Agency (EMA) reported that in 2022, it recommended 89 medicines for marketing authorization, all of which must comply with these stringent bio decontamination standards.

Furthermore, Europe has a booming pharmaceutical and biotechnology industry, which is a major driver of the bio decontamination market. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical industry invested around €44.5 billion in R&D in Europe in 2022. This significant investment in R&D demands modern bio decontamination solutions to provide sterile environments for medication development and manufacturing activities.

Global Bio Decontamination Market: Segmentation Analysis

The Bio Decontamination Market is segmented based on Product, Type, Agent, End-User, and Geography.

Bio Decontamination Market, By Product

• Equipment
• Consumables

Based on Product, the market is segmented into Equipment and Consumables. The equipment segment is estimated to dominate the bio decontamination market. This segment includes devices like hydrogen peroxide vaporizers, chlorine dioxide generators, and peracetic acid systems, which are essential for disinfecting and sterilizing surfaces, equipment, and environments in a variety of industries, including healthcare, pharmaceuticals, and biotechnology. The increased demand for this equipment reflects the growing requirement for effective bio-decontamination solutions to minimize illness transmission and assure product safety.

Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

Based on Type, the Bio Decontamination market is segmented into Chamber Decontamination and Room Decontamination. The chamber decontamination segment is estimated to dominate the market over the forecast period due to the widespread adoption of chamber-based bio decontamination systems in pharmaceutical, biotechnology, and research laboratories. These enclosed chambers provide regulated and effective decontamination of equipment, tools, and other key infrastructure, making them the ideal method for maintaining sterile workplaces in high-risk industries.

Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

Based on Agent, the market is divided into Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, and Nitrogen Dioxide. The hydrogen peroxide segment is estimated to dominate the global market. Hydrogen peroxide is used because it is efficient against a wide range of microorganisms, including spores, and may permeate surfaces and equipment. The advantages of hydrogen peroxide over other agents, such as its quick action, low toxicity, and ease of monitoring, are responsible for the segment's dominance in the bio decontamination market.

Bio Decontamination Market, By End-User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

Based on End-User, the market is segmented into Pharmaceutical & Medical Device Manufacturers, Contract Manufacturing & Research Organizations, Hospital & Healthcare Facilities, and Others. The pharmaceutical & medical device manufacturers segment is estimated to dominate this segment in the forecast period due to the strict regulatory standards imposed by agencies, which need cleaning and sterilizing operations to prevent product contamination. The growing frequency of product recalls due to contamination issues has spurred the use of bio decontamination solutions by pharmaceutical and medical device makers to maintain product quality and safety.

Bio Decontamination Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the bio decontamination market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate the bio decontamination market during the forecast period due to the healthcare sector's rapid expansion, rising occurrences of hospital-acquired illnesses, an aging population, and increased government programs and investments in healthcare facility sanitation.

Key Players

• The "Bio Decontamination Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are STERIS (U.S.), Bioquell (Ecolab) (U.K.), JCE Biotechnology (France), Fedegari Autoclavi S.p.A. (Italy), and TOMI Environmental Solutions, Inc. (U.S.).

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Bio Decontamination Market Recent Developments
• In July 2024, Ecolab's Bioquell HPV-AQ was granted authorization for use in all European Union and European Economic Area territories.
• In December 2024, TOMI Environmental Solutions, Inc. introduced new SteraMist products, including the Select Plus, a hybrid solution that combines the company's current Surface Select and Environment systems.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bio Decontamination Market, By Product

• Equipment
• Consumables

5. Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

6. Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

7. Bio Decontamination Market, By End User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• STERIS (U.S.)
• Bioquell (Ecolab) (U.K.)
• JCE Biotechnology (France)
• Fedegari Autoclavi S.p.A. (Italy)
• TOMI Environmental Solutions, Inc. (U.S.)

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References